Carlos Cuesta-Mateos
4PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Aug 07, 2023
Evaluation of the novel therapeutic anti-CCR7 antibody CAP-100 as an add-on therapy in chronic lymphocytic leukemia patients receiving venetoclax.Tamara Mateu-Albero, Ana Marcos-Jimenez, Pablo Delgado-Wicke
|Jun 10, 2022
Ibrutinib Does Not Impact CCR7-Mediated Homeostatic Migration in T-Cells from Chronic Lymphocytic Leukemia Patients.Tamara Mateu-Albero, Ana Marcos-Jimenez, Stefanie Wissmann
|Jul 23, 2021
Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia and its implication for the activity of CAP-100, a novel therapeutic anti-CCR7 antibody.Tamara Mateu-Albero, Raquel Juárez-Sánchez, Javier Loscertales
|Oct 28, 2020
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia.Carlos Cuesta-Mateos, Patricia Fuentes, Alexandra Schrader
Pageof 1
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=75)
